Comparison Between Two Different Dosages of Remifentanil During Colonoscopy

San Donato Group (GSD)

Status and phase: Completed; Phase 4

Conditions: Colonoscopy

Treatments: Drug: Remifentanil; Drug: Meperidine

Study type: Interventional

Funder types: Other

Identifiers

NCT01229527

PCSA/Remi 2009

Details and patient eligibility

About

The purpose of this randomized double-blind trial is to define the correct dosage of Remifentanil during operative and diagnostic endoscopic procedures. In particular we want to analyze if the administration of Remifentanil by PCSA (Patient Controlled Sedation and Analgesia) is a good method during colonoscopy, evaluating pain control, discharge time and side effects.

90 patients undergoing colonoscopy will be enrolled.

Enrollment: 90 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult Patients
• Diagnostic and Operative Colonoscopy
• ASA Physical Status I-II

Exclusion criteria

• Age < 18 years

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

90 participants in 3 patient groups

Remifentanil RS1

Experimental group

Treatment:

Drug: Remifentanil

Drug: Remifentanil

Remifentanil RS2

Experimental group

Treatment:

Drug: Remifentanil

Drug: Remifentanil

Meperidine

Active Comparator group

Treatment:

Drug: Meperidine